Winship Cancer Institute
Emory University
Atlanta, GA
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Classifications
Explore trials based on treatment classification/type.
Targets
Explore trials based on treatment targets.
MSK Service
Filter trials based on MSK Service
Accepting patients
CARTITUDE-2
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
Learn more- CAR T Cell
- BCMA
- Phase 2
- Myeloma Service
- 21-009
Accepting patients
RedirecTT-1
A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection Antibodies Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- GPRC5D
- Phase 1/2
- Myeloma Service
- 23-259
Not yet accepting
MagnetisMM-30
A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- BCMA
- CD3
- Phase 1
- Myeloma Service
Accepting patients
BGB-11417
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations With Dexamethasone and Carfilzomib in Multiple Myeloma
Learn more- BCL-2 Inhibitor
- Phase 1/2
- Has results
- Myeloma Service
- 23-020
Accepting patients
Cemsidomide (CFT7455)
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Learn more- IKZF1/3
- Phase 1/2
- Myeloma Service
- 21-301
Accepting patients
MMSET Inhibitor
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Learn more- Phase 1
- Myeloma Service
- 23-222